
ACAD EPS Estimates
ACADIA Pharmaceuticals Inc.
$17.66
-$0.17(-0.98%)
50
Overall
75
Value
18
Tech
57
Quality
Market Cap
$3.05B
Volume
861.71K
52W Range
$15.86 - $30.96
Target Price
$30.05
ACAD EPS estimates: the consensus estimate for ACADIA Pharmaceuticals Inc.'s current fiscal year is $0.76 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ACAD EPS Estimates
- EPS estimate, current quarter
- $0.28
- EPS estimate, next quarter
- $0.20
- EPS estimate, current year
- $0.76
- EPS estimate, next year
- $1.08
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2012 | $-0.38 |
| 2011 | $-0.44 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACAD | $17.66 | -1.0% | 861.71K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ACADIA Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW